GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) » Definitions » ROIC %

Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) ROIC % : 7.48% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Laboratorio Farmaceutico Erfo SpA ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Laboratorio Farmaceutico Erfo SpA's annualized return on invested capital (ROIC %) for the quarter that ended in Jun. 2024 was 7.48%.

As of today (2025-03-31), Laboratorio Farmaceutico Erfo SpA's WACC % is 9.46%. Laboratorio Farmaceutico Erfo SpA's ROIC % is 5.56% (calculated using TTM income statement data). Laboratorio Farmaceutico Erfo SpA earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Laboratorio Farmaceutico Erfo SpA ROIC % Historical Data

The historical data trend for Laboratorio Farmaceutico Erfo SpA's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Farmaceutico Erfo SpA ROIC % Chart

Laboratorio Farmaceutico Erfo SpA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROIC %
37.22 24.11 21.18 11.81 7.99

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROIC % Get a 7-Day Free Trial Premium Member Only 18.26 7.90 12.82 3.54 7.48

Competitive Comparison of Laboratorio Farmaceutico Erfo SpA's ROIC %

For the Packaged Foods subindustry, Laboratorio Farmaceutico Erfo SpA's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorio Farmaceutico Erfo SpA's ROIC % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Laboratorio Farmaceutico Erfo SpA's ROIC % distribution charts can be found below:

* The bar in red indicates where Laboratorio Farmaceutico Erfo SpA's ROIC % falls into.


;
;

Laboratorio Farmaceutico Erfo SpA ROIC % Calculation

Laboratorio Farmaceutico Erfo SpA's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROIC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=0.919 * ( 1 - 27.61% )/( (8.021 + 8.638)/ 2 )
=0.6652641/8.3295
=7.99 %

where

Laboratorio Farmaceutico Erfo SpA's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Jun. 2024 is calculated as:

ROIC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=0.898 * ( 1 - 30.24% )/( (8.638 + 8.105)/ 2 )
=0.6264448/8.3715
=7.48 %

where

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratorio Farmaceutico Erfo SpA  (MIL:ERFO) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Laboratorio Farmaceutico Erfo SpA's WACC % is 9.46%. Laboratorio Farmaceutico Erfo SpA's ROIC % is 5.56% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Laboratorio Farmaceutico Erfo SpA ROIC % Related Terms

Thank you for viewing the detailed overview of Laboratorio Farmaceutico Erfo SpA's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorio Farmaceutico Erfo SpA Business Description

Traded in Other Exchanges
Address
Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.

Laboratorio Farmaceutico Erfo SpA Headlines

No Headlines